Loading insider details...
Beta
Latest Form 4 (Sep 3, 2026): Sale of 132 ONC shares, $47.0K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 3, 2026 | BeOne Medicines Ltd. (ONC) | Sale | 132 | $47.0K |
| Jun 15, 2026 | BeOne Medicines Ltd. (ONC) | Grant/Award | 31,213 | n/a |
| Jun 10, 2026 | BeOne Medicines Ltd. (ONC) | Sale | 100 | $27.1K |
| Sep 4, 2025 | BeOne Medicines Ltd. (ONC) | Sale | 122 | $39.9K |
| Jun 12, 2025 | BeOne Medicines Ltd. (ONC) | Grant/Award | 29,601 | n/a |
| Sep 5, 2024 | BeiGene, Ltd. (BGNE) | Sale | 137 | $26.0K |
| Jun 7, 2024 | BeiGene, Ltd. (BGNE) | Grant/Award | 24,427 | n/a |
| Feb 3, 2021 | CARLISLE COMPANIES INC (CSL) | Grant/Award | 505 | n/a |
| Jan 5, 2021 | CARLISLE COMPANIES INC (CSL) | Grant/Award | 984 | n/a |
| Feb 5, 2020 | CARLISLE COMPANIES INC (CSL) | Grant/Award | 455 | n/a |